DOI QR코드

DOI QR Code

Impact of Heterogeneous Overlapping Drug-Eluting Stents on the Arterial Responses of Rabbit Iliac Arteries: A Comparison With Overlapping Bare Metal Stents

  • Rha, Seung-Woon (Cardiovascular Center, Korea University Guro Hospital) ;
  • Chen, Kang-Yin (Cardiovascular Center, Korea University Guro Hospital) ;
  • Oh, Dong-Joo (Cardiovascular Center, Korea University Guro Hospital) ;
  • Li, Yong-Jian (Cardiovascular Center, Korea University Guro Hospital) ;
  • Jin, Zhe (Cardiovascular Center, Korea University Guro Hospital) ;
  • Podda, Kanhaiya Lal (Cardiovascular Center, Korea University Guro Hospital) ;
  • Ramasamy, Sureshkumar (Cardiovascular Center, Korea University Guro Hospital) ;
  • Minami, Yoshiyasu (Cardiovascular Center, Korea University Guro Hospital) ;
  • Elnaga, Amro (Cardiovascular Center, Korea University Guro Hospital) ;
  • Choi, Byoung-Geol (Cardiovascular Center, Korea University Guro Hospital) ;
  • Hong, Sang-Pyo (Cardiovascular Center, Korea University Guro Hospital) ;
  • Cheon, Byoung-Won (Cardiovascular Center, Korea University Guro Hospital) ;
  • Moon, Sang-Ki (Cardiovascular Center, Korea University Guro Hospital) ;
  • Im, Sung-Il (Cardiovascular Center, Korea University Guro Hospital) ;
  • Kim, Sun-Won (Cardiovascular Center, Korea University Guro Hospital) ;
  • Na, Jin-Oh (Cardiovascular Center, Korea University Guro Hospital) ;
  • Choi, Cheol-Ung (Cardiovascular Center, Korea University Guro Hospital) ;
  • Lim, Hong-Euy (Cardiovascular Center, Korea University Guro Hospital) ;
  • Kim, Jin-Won (Cardiovascular Center, Korea University Guro Hospital) ;
  • Kim, Eung-Ju (Cardiovascular Center, Korea University Guro Hospital) ;
  • Han, Seong-Woo (Cardiovascular Center, Korea University Guro Hospital) ;
  • Park, Chang-Gyu (Cardiovascular Center, Korea University Guro Hospital) ;
  • Seo, Hong-Seog (Cardiovascular Center, Korea University Guro Hospital) ;
  • Kim, Jung-Ha (Cardiovascular Center, Chonnam National University Hospital) ;
  • Hong, Young-Joon (Cardiovascular Center, Chonnam National University Hospital) ;
  • Jeong, Myung-Ho (Cardiovascular Center, Chonnam National University Hospital)
  • Published : 2012.06.30

Abstract

Background and Objectives: Although the use of heterogeneous overlapping drug-eluting stents (DES) is not uncommon in clinical practice, whether the implantation sequences of heterogeneous DES will influence the endothelialization or arterial responses differently remains unclear. Materials and Methods: Twenty-one rabbits were randomized to receive overlapping stents in the iliac artery for 3 months {distal sirolimuseluting stent (SES, $Cypher^{TM}$)+proximal paclitaxel-eluting stent (PES, $Taxus^{TM}$) (C+T, n=7), distal Taxus+proximal Cypher (T+C, n=7) and bare metal stent (BMS)+BMS (B+B, n=7)}. Endothelial function was evaluated by the acetylcholine provocation test during follow-up angiography. Histopathological changes in proximal, overlapped, and distal stented segments were evaluated. Results: Although the overall angiographic outcomes were comparable, late loss (mm) in the distal stented segment was higher in the B+B (0.39${\pm}$0.07) and C+T (0.40${\pm}$0.20) than that in the T+C (0.06${\pm}$0.02) group (p<0.001). The incidence of acetylcholine-induced spasm was higher in the DES groups compared with BMS, regardless of the implantation sequences (85.7% in C+T vs. 14.3% in B+B vs. 71.4% in T+C, p=0.017). Notably, only the distal Cypher implantation group (C+T) had three cases of stent fracture. A histopathological analysis showed that despite similar arterial injury scores, Taxus and Cypher stents had higher inflammatory reactions at the overlapped and distal segments compared with those of BMS. Conclusion: Despite similar arterial injury, higher inflammatory reactions were observed in overlapping DES segments regardless of the implantation sequence compared with that of BMS. Moreover, DES was associated with impaired endothelial function on the adjacent nonstented segments.

Keywords

References

  1. Kang WC, Oh KJ, Han SH, et al. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxeleluting stents: comparison with same drug-eluting overlapping stents. Int J Cardiol 2007;123:12-7. https://doi.org/10.1016/j.ijcard.2006.11.104
  2. Her SH, Yoo KD, Park CS, et al. Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents. Heart 2011;97:1501-6. https://doi.org/10.1136/hrt.2011.226308
  3. Kim JW, Seo HS, Park JH, et al. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. J Am Coll Cardiol 2009;53:1653-9. https://doi.org/10.1016/j.jacc.2009.01.051
  4. Obata JE, Kitta Y, Takano H, et al. Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction. J Am Coll Cardiol 2007;50:1305-9. https://doi.org/10.1016/j.jacc.2007.06.031
  5. Lim SY, Jeong MH, Hong SJ, et al. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of instent restenosis. Circ J 2008;72:463-8. https://doi.org/10.1253/circj.72.463
  6. Lim SY, Bae EH, Jeong MH, et al. Effect of alpha lipoic acid in a porcine in-stent restenosis model. J Cardiol 2009;54:375-85. https://doi.org/10.1016/j.jjcc.2009.06.005
  7. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992;19:267-74. https://doi.org/10.1016/0735-1097(92)90476-4
  8. Hong YJ, Jeong MH, Lee SR, et al. Anti-inflammatory effect of abciximab- coated stent in a porcine coronary restenosis model. J Korean Med Sci 2007;22:802-9. https://doi.org/10.3346/jkms.2007.22.5.802
  9. Serruys PW, Foley DP, Suttorp MJ, et al. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. J Am Coll Cardiol 2002;39:393-9.
  10. Colombo A, Chieffo A. Drug-eluting stent update 2007: part III: technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation 2007;116:1424-32. https://doi.org/10.1161/CIRCULATIONAHA.106.621359
  11. Tsagalou E, Chieffo A, Iakovou I, et al. Multiple overlapping drugeluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005;45:1570-3. https://doi.org/10.1016/j.jacc.2005.01.049
  12. Chu WW, Kuchulakanti PK, Torguson R, et al. Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention. Am J Cardiol 2006;98:1563-6. https://doi.org/10.1016/j.amjcard.2006.07.032
  13. Holmes DR Jr, Kereiakes DJ, Garg S, et al. Stent thrombosis. J Am Coll Cardiol 2010;56:1357-65. https://doi.org/10.1016/j.jacc.2010.07.016
  14. Nakazawa G, Finn AV, Joner M, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008;118:1138-45. https://doi.org/10.1161/CIRCULATIONAHA.107.762047
  15. Cook S, Ladich E, Nakazawa G, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009;120:391-9. https://doi.org/10.1161/CIRCULATIONAHA.109.854398
  16. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimusor paclitaxel-eluting stents. Circulation 2005;112:270-8. https://doi.org/10.1161/CIRCULATIONAHA.104.508937
  17. Wilson GJ, Nakazawa G, Schwartz RS, et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009;120:141-9. https://doi.org/10.1161/CIRCULATIONAHA.107.730010
  18. Shinke T, Li J, Chen JP, et al. High incidence of intramural thrombus after overlapping paclitaxel-eluting stent implantation: angioscopic and histopathologic analysis in porcine coronary arteries. Circ Cardiovasc Interv 2008;1:28-35. https://doi.org/10.1161/CIRCINTERVENTIONS.108.770008
  19. Chhatriwalla AK, Cam A, Unzek S, et al. Drug-eluting stent fracture and acute coronary syndrome. Cardiovasc Revasc Med 2009;10:166-71. https://doi.org/10.1016/j.carrev.2009.02.003

Cited by

  1. Meta-Analysis of Drug-Eluting Balloon Angioplasty and Drug-Eluting Stent Placement for Infrainguinal Peripheral Arterial Disease vol.26, pp.4, 2015, https://doi.org/10.1016/j.jvir.2014.12.013
  2. Systematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery Revascularization vol.51, pp.2, 2012, https://doi.org/10.1177/1538574416689426